Knowledge Network Node

Inhibited PI3K Synergism with TRAIL to Induce Apoptosis in Breast Cancer MCF- 7 CellsChinese Full Text

ZHU Ming-Yue;LI Wei;XIA Hua;LU Yan;DONG Xu;CHEN Yi;GUO Jun-Li;FU Shi-Gan;XIE Xie-Ju;LI Meng-Sen;Agriculture College of Hainan University;Hainan Key Laboratory of Carcinogenesis and Intervention,Hainan Medical College;Key Laboratory of Molecular and Biology,Hainan Medical College;Department of Pathophysiology,Hainan Medical College;Tumor Institute of Hainan Medical College;

Abstract: Tumor necrosis factor-related apoptosis-inducing ligand( TRAIL) is a member of the tumor necrosis factor( TNF) superfamily and has been shown to induce extrinsic pathway of apoptosis in many types of cancer cells,but in breast cancer MCF-7 cell it displayed resistance to cytotoxicity of TRAIL.This investigation aim to study the effect of phosphatidylinositol 3-kinase( PI3K) signal pathway on MCF-7 cells resisted the cytotoxicity of TRAIL. Human breast cancer MCF-7 cells were treated with TRAIL or Ly294002 alone /in combination. MTT cell viability assay was used to evaluate growth of the cells. For showing the change of morphology and nucleolus in MCF-7 cells,both microscopical photograph and 4,6-diamino-2-phenylindole( DAPI) stained detects were performed. Flow cytometry was applied to analyze the apoptosis of the cells; Laser confocal microscopy was applied to observe location and migration of poly( ADP-ribose) polymerase-1( PARP-1) and Western blot analysis was conducted to evaluate DR4,DR5,DcR1,DcR2,caspase-3 /8,Src and pAKT( Ser473) protein levels. The results indicated that sequential treatment of small dose of Ly294002( !40 μmol /L) or TRAIL( !80 nmol /L) had little suppressive impact on the growth,but Ly294002( 80 μmol /L) or TRAIL( 160 nmol /L) significant inhibited the proliferation of MCF-7 cells. Pretreated with Ly294002( 20 μmol /L) followed treated with TRAIL( 40 nmol /L)resulted in significant synergistic cytotoxicity and apoptosis,suggesting that MCF-7 cells were under strong apoptotic stimuli. Western blot assay showed that MCF-7 expressed DR4,DR5,DcR1,DcR2,caspase-8. Pretreatment of MCF-7 cells with Ly294002( 20 μmol /L) and followed treat with TRAIL( 40nmol /L) not only promoted PARP-1 to enter cytoblast,but also suppressed the expression of Src and pAKT( Ser473) in the cancer cells. These findings strongly suggest that inhibition of PI3K /AKT signal enhances sensitivity of MCF-7 cells to TRAIL; MCF-7 cells resistance the apoptosis induced by TRAIL via activation of PI3K /AKT signal pathway to stimulate the expression of Src. These demonstrated that the results make Ly294002 and TRAIL a novel combination treatment candidate for breast cancer.
  • DOI:

    10.13865/j.cnki.cjbmb.2014.07.008

  • Series:

  • Subject:

  • Classification Code:

    R737.9

  • Mobile Reading
    Read on your phone instantly
    Step 1

    Scan QR Codes

    "Mobile CNKI-CNKI Express" App

    Step 2

    Open“CNKI Express”

    and click the scan icon in the upper left corner of the homepage.

    Step 3

    Scan QR Codes

    Read this article on your phone.

  • HTML
  • CAJ Download
  • PDF Download

Download the mobile appuse the app to scan this coderead the article.

Tips: Please download CAJViewer to view CAJ format full text.

Download: 321 Page: 668-677 Pagecount: 10 Size: 1614K

Related Literature
  • Similar Article
  • Reader Recommendation
  • Associated Author